AG真人官方

IDEAYA Biosciences (IDYA) filed a Form S-8 on 5 Aug 2025 to register 2,000,000 additional common shares for issuance under its 2023 Employment Inducement Award Plan, raising the total shares registered for the plan to 4 million. The plan, adopted and amended by the board under Nasdaq Rule 5635(c)(4) without shareholder approval, is intended to grant equity awards to new hires. The filing incorporates by reference the company鈥檚 2024 Form 10-K, 2025 Form 10-Qs and recent 8-Ks, and includes customary legal opinions and consents. No financial performance data or changes to corporate strategy are disclosed; the action is administrative and may cause modest dilution if all shares are issued.

On 07/30/2025, CVI Investments, Inc. and its investment manager, Heights Capital Management, Inc., filed a Schedule 13G declaring passive ownership in Dragonfly Energy Holdings Corp. (common stock, CUSIP 26145B304). The two entities jointly report 3,800,000 shares held with shared voting and dispositive power and no sole authority. Based on 61,724,470 shares outstanding (per the Company鈥檚 07/30/2025 prospectus supplement), the stake equals 6.2 % of the public float.

The filing is made under Rule 13d-1(c), signaling a non-activist, passive investment. Both parties expressly disclaim additional beneficial ownership beyond their pecuniary interest. The certification affirms the shares were not acquired to influence control. The document was signed by Sarah Travis, Assistant General Counsel at Heights Capital, on 08/04/2025.

Azul S.A. (B3: AZUL4; OTC: AZULQ) filed a Form 6-K announcing that on 31 Jul 2025 it entered into a Backstop Commitment Agreement (BCA) with certain investors covering an equity capital raise of up to US$650 million.

The backstop parties agree to purchase any unsubscribed shares, guaranteeing full capitalization, but the arrangement is subject to U.S. Bankruptcy Court approval within the company鈥檚 ongoing Chapter 11 cases. Azul will file a motion seeking such approval and will notify stakeholders once a hearing is scheduled.

• Equity raise: up to US$650 m
• Status: conditional on court approval
• Objective: strengthen liquidity during restructuring
• Operations: carrier says flights and customer service remain 鈥渟eamless鈥�

No financial or traffic metrics were provided. Management reiterated its commitment to transparency and directs stakeholders to its dedicated restructuring sites for further information.

Viking Holdings Ltd (VIK) 鈥� Form 144 overview: The filing discloses that insider Jeffrey Dash has notified the SEC of his intent to sell up to 25,000 ordinary shares of Viking Holdings through broker Morgan Stanley Smith Barney LLC. The proposed sale, scheduled for 01 July 2025, carries an aggregate market value of $1.33 million, based on prevailing market prices. Viking currently has 314,950,576 shares outstanding; the new sale therefore represents roughly 0.008 % of total shares.

Recent 10b5-1 activity: The same account has conducted four 10b5-1 sales in the last three weeks, totaling 150,000 shares for gross proceeds of $7.33 million (06/12/2025鈥�06/26/2025). Including the newly noticed shares, cumulative planned and completed sales over the period reach 175,000 shares, or about 0.055 % of shares outstanding.

Key contextual points for investors:

• The filing is solely a notice of intention; the sale may or may not occur, but the insider must file if the sale could exceed Rule 144 thresholds.
• Sales are being made under a pre-arranged Rule 10b5-1 plan, which can mitigate concerns of trading on undisclosed information.
• The dollar amounts are modest relative to Viking鈥檚 equity base, yet a pattern of insider liquidation鈥攅ven in small increments鈥攃an influence sentiment, particularly for newly public or thinly traded stocks.

Bowman Consulting Group Ltd. (BWMN) 鈥� Form 4 filing: Director Patricia Mulroy reported selling 400 shares of common stock on 06/30/2025 at $29.06 per share. The transaction was executed under a Rule 10b5-1 trading plan adopted on 03/14/2025 that permits the sale of up to 800 shares between June and July 2025. After the sale, Mulroy directly owns 23,136 shares. No derivative securities were involved, and there were no other transactions disclosed in this filing.

IZEA Worldwide, Inc. (ticker: IZEA) filed a Form 4 on 1 July 2025 reporting that director Daniel R. Rua received 5,882 shares of common stock on 30 June 2025. The shares represent payment of Q2 2025 director fees valued at $15,000, calculated at the closing market price of $2.55 per share on the grant date. The restricted-stock award vested immediately and was acquired at $0 cash cost. Following the grant, Rua鈥檚 direct beneficial ownership increased to 85,259 shares. No derivative securities, sales, or additional transactions were disclosed, and the filing was made under Rule 10b5-1.

Everi Holdings Inc. (EVRI) has filed Post-Effective Amendment No. 1 to twelve prior Form S-8 registration statements that collectively covered more than 48 million shares issued under a variety of legacy equity incentive plans. The amendment formally deregisters all unsold shares that remained available under those plans.

The filing follows the July 1, 2025 closing of a multi-party transaction under which funds managed by affiliates of Apollo Global Management (through Voyager Parent, LLC) simultaneously acquired both Everi and International Game Technology PLC鈥檚 (IGT) Gaming & Digital business. Key transaction steps included:

• IGT鈥檚 transfer of substantially all Gaming & Digital assets and liabilities to a new subsidiary, Ignite Rotate LLC (鈥淪pinco鈥�).
• Buyer鈥檚 purchase of all Spinco units from IGT and, through an affiliate, all shares of IGT Canada Solutions ULC.
• Merger: Voyager Merger Sub, Inc. merged with and into Everi, leaving Everi as a wholly-owned subsidiary of Buyer.

Because Everi鈥檚 common stock is being delisted and deregistered under Section 12(b) of the Exchange Act, the company is terminating all related Securities Act offerings. The amendment therefore renders the referenced S-8 registration statements ineffective and removes any remaining unsold shares from registration. Signatures from the full board and senior officers, including President & CEO Randy L. Taylor and CFO Mark F. Labay, authorize the filing.

Investor takeaway: the amendment is an administrative step confirming that Everi鈥檚 equity will no longer trade publicly or be issued under employee stock plans following completion of the Apollo-led acquisition.

John Wiley & Sons, Inc. (WLYB) has filed a Form 144 indicating an intended sale of 5,665 shares of its common stock through UBS Financial Services on the NYSE, with an aggregate market value of $250,053. Based on the figures supplied, the reference price is roughly $44 per share. The shares to be sold represent approximately 0.013 % of the company鈥檚 44.62 million shares outstanding, making the planned disposition immaterial in percentage terms.

The stock was acquired via the vesting of multiple tranches of restricted stock units (RSUs) and performance share units (RPSUs) granted between April 2021 and April 2023. Tranche sizes range from 191 to 1,565 shares, reflecting normal equity-compensation practices. The filer reported no sales during the prior three-month period and certified the absence of undisclosed material adverse information.

Form 144 is a notice of proposed, not completed, sales. The filing does not disclose the seller鈥檚 identity, whether a Rule 10b5-1 trading plan exists, or final execution prices. Given the modest size of the transaction and its origin from routine incentive-compensation vesting, the event is unlikely to influence WLYB鈥檚 share price materially, but it remains a data point for investors monitoring insider-selling patterns.